Correction to: Nature Reviews Clinical Oncology https://doi.org/10.1038/s41571-022-00620-6, published online 30 March 2022.
In the original version of this Review, ref. 177 was a study that does not apply to a discussion of CLEVER-1. The relevant study is: Virtakoivu, R. et al. Systemic blockade of Clever-1 elicits lymphocyte activation alongside checkpoint molecule downregulation in patients with solid tumors: results from a phase I/II clinical trial. Clin. Cancer Res. 27, 4205–4220 (2021). Ref. 177 has been corrected in the HTML and PDF versions of the article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pittet, M.J., Michielin, O. & Migliorini, D. Author Correction: Clinical relevance of tumour-associated macrophages. Nat Rev Clin Oncol 19, 424 (2022). https://doi.org/10.1038/s41571-022-00632-2
Published:
Issue date:
DOI: https://doi.org/10.1038/s41571-022-00632-2
This article is cited by
-
Unraveling the role of M2 TAMs in ovarian cancer dynamics: a systematic review
Journal of Translational Medicine (2025)
-
Identification of M0 macrophage associated lipid metabolism genes for prognostic and immunotherapeutic response prediction in hepatocellular carcinoma
Discover Oncology (2025)
